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MaOBJECTIVES The objective of this study was to determine which strain component assessed by 2-dimensional
speckle-tracking echocardiography (2DSTE) and 3-dimensional speckle-tracking echocardiography (3DSTE) was the most
powerful predictor for futuremajor adverse cardiac events (MACE) in asymptomatic patientswith severe aortic stenosis (AS).
BACKGROUND Ongoing debate exists regarding the appropriateness of early surgery in asymptomatic severe AS
and preserved left ventricular ejection fraction (LVEF). Previous studies showed that 2-dimensional global longitudinal
strain (2DGLS) was a signiﬁcant predictor in asymptomatic severe AS patients. However, the prognostic utility of
3DSTE-derived multidirectional strain parameters has not been investigated in these patients.
METHODS We enrolled 104 asymptomatic severe AS patients (indexed aortic valve area <0.6 cm2/m2) and pre-
served LVEF and performed strain analysis using both 2DSTE and 3DSTE. Two-dimensional and 3-dimensional global
longitudinal, circumferential, and radial strain and global 3-dimensional strain were measured in each patient. All patients
were followed to record MACE.
RESULTS During a median follow-up of 373 days, MACE developed in 33 patients (32%). 2DGLS (14.7  3.3 vs. 16.3
 3.3, p ¼ 0.0168), 3DGLS (13.5  2.5 vs. 16.1  2.4, p < 0.0001) and 3-dimensional global radial strain (3DGRS)
(35.9  4.5 vs. 38.1  4.4, p ¼ 0.0209) were signiﬁcantly impaired in patients with MACE compared with those without
MACE. Kaplan-Meier analysis showed 2DGLS (cutoff: 17.0%), 3DGLS (cutoff: 14.5%), and 3DGRS (cutoff: 39.0%)
provide a signiﬁcant difference in MACE rate. Receiver-operating characteristic analysis revealed that the area under the
curve of 3DGLS for MACE (0.78) was signiﬁcantly larger than that of 2DGLS (0.62, p ¼ 0.0044) and 3DGRS (0.66,
p ¼ 0.0069). Separate multivariate analysis revealed 3DGLS was only signiﬁcant as independent predictor for future
MACE after correcting for mean pressure gradient and left ventricular mass index.
CONCLUSIONS 3DGLS is the most robust index for predicting future adverse cardiac events in asymptomatic
severe AS patients with preserved LVEF. (J Am Coll Cardiol Img 2015;8:235–45) © 2015 by the American College of
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ABBR EV I A T I ON S
AND ACRONYMS
2D = 2-dimensional
3D = 3-dimensional
3DGS = 3-dimensional
global strain
AS = aortic stenosis
AUC = area under the curve
AVA = aortic valve area
AVR = aortic valve
replacement
GCS = global circumferential
strain
GLS = global longitudinal
strain
GRS = global radial strain
iAVA = indexed aortic
valve area
LA = left atrial
LV = left ventricular
LVEF = left ventricular
ejection fraction
MACE = major adverse
cardiac event(s)
PG = pressure gradient
ROC = receiver-operating
characteristic
STE = speckle-tracking
echocardiography
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236C alciﬁc aortic stenosis (AS) is the mostcommon form of valvular heart dis-ease in developed countries, and
the number of affected individuals is rapidly
growing as life expectancy increases (1,2).
Symptomatic severe AS patients and asymp-
tomatic severe AS patients with impaired
left ventricular (LV) function have Class I in-
dications for aortic valve replacement (AVR)
according to 2014 AHA/ACC guideline for the
management of patients with valvular heart
disease (2,3). However, there are ongoing
debates regarding early surgery or watchful
waiting in asymptomatic severe AS and pre-
served LV ejection fraction (LVEF) (4–6). Sub-
endocardial ﬁbrosis caused by increased
mechanical stress imposed by AS itself is
observed, even in normal LVEF (7). Moreover,
LVEF is not a sensitive marker for detecting
subclinical LV dysfunction (8). Therefore, a
more sophisticated approach to evaluating
LV mechanics is mandatory for selecting
high-risk asymptomatic patients with severe
AS and preserved patients who should un-
dergo early surgical intervention. Among
several proposed echocardiographic parame-
ters for predicting adverse outcomes,
global longitudinal strain (GLS) assessed by
2-dimensional (2D) speckle-tracking analysiscan provide useful prognostic information (9–11).
However, 2D strain measurements have the inherent
limitation of losing speckles from out-of-plane cardiac
motion (12). Three-dimensional speckle-tracking
echocardiography (3DSTE), on the other hand, has
the capability to overcome these drawbacks (13,14).SEE PAGE 246However, it has not been determined which directions
of strain components measured by 3DSTE are the
best predictors of future prognosis in this subset of
patients. Accordingly, we aimed to investigate the
impairment of multidirectional strain components
using 3DSTE in asymptomatic patients with severe
AS and preserved ejection fraction and to eluci-
date which strain assessed by both 2-dimensional
speckle-tracking echocardiography (2DSTE) and
3DSTE is the more robust predictor of future major
adverse cardiac events (MACE) in these patients.
METHODS
STUDY SUBJECTS. We enrolled patients with AS
who underwent transthoracic 3-dimensional (3D)
echocardiography from 3 cardiovascular institutions.3D echocardiography dataset acquisitions were
performed at the time of clinically indicated
echocardiography examinations in each hospital from
January 2011 to February 2014. At the same time,
attending physicians performed careful history tak-
ing regarding AS-related symptoms in these patients.
The inclusion criteria in this study were patients with
severe AS deﬁned as indexed aortic valve area
(iAVA) <0.6 cm2/m2, preserved LVEF (LVEF >50%),
and no recorded symptoms relating to AS. We
excluded patients who had <2 months of follow-up
and those who had underwent AVR within 2 months
after echocardiographic examination. Clinical char-
acteristics including hypertension, diabetes mellitus,
hyperlipidemia, chronic kidney disease, and coronary
artery disease were documented at the time of
echocardiography examination. Chronic kidney dis-
ease was deﬁned as an estimated glomerular ﬁltra-
tion rate <60 ml/min/1.73 m2. The study was
approved by the Ethics Committee at each hospital,
and informed consent was obtained from all subjects.
STANDARD ECHOCARDIOGRAPHY. Comprehensive
2D and Doppler echocardiography were performed
using a commercially available ultrasound machine
and transducer (iE33, Philips Medical System, An-
dover, Massachusetts or Vivid 7 or E9, GE Health-
care, Horten, Norway). Views from 3 short axes
(basal, middle, and apical) and 3 apical axes (apical
4-chamber, 2-chamber, and long-axis views) that
encompassed the whole part of the left ventricle were
acquired. Pulsed-wave Doppler examination of LV
inﬂow and outﬂow and tissue Doppler examination
of the mitral annulus were performed according
to the American Society of Echocardiography re-
commendations (15). Flow velocity across the aortic
valve was measured at multiple transducer positions
using continuous-wave Doppler and peak and mean
pressure gradients (PGs) were calculated with a
simpliﬁed Bernoulli equation. Aortic valve area (AVA)
was calculated using the continuity equation. LV
volume measurements were performed using 3DSTE.
3D ECHOCARDIOGRAPHY. 3D full-volume datasets
were acquired from the apical transducer position
during held respiration by a fully sampled matrix
array transducer (X5-1/X3-1, Philips Medical Systems
or 4V, GE Healthcare). To ensure the inclusion of the
entire left ventricle within the pyramidal scan vol-
ume with a relatively high volume rate, datasets
throughout 1 cardiac cycle were acquired using the
wide-angle mode, wherein multiple wedge-shaped
subvolumes were acquired with electrocardio-
graphic gating during a single 5-s to 7-s breath-
hold (16).
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2372D SPECKLE-TRACKING ECHOCARDIOGRAPHY.
2D speckle-tracking analysis was performed using
vendor-independent 2D speckle-tracking software
(2D Cardiac Performance Analysis, TomTec Imaging
Systems, Unterschleissheim, Germany). Radial and
circumferential strains were determined by endocar-
dial tracing in the 3 levels of short-axis views.
Longitudinal strain was measured by manual tracing
of the endocardial border in the 3 apical views. After
speckle-tracking analysis of the LV endocardium on a
frame-by-frame basis during 1 cardiac cycle, the
software provides regional strain curves of 6 seg-
ments (4 segments in the apical short-axis view) in
each view, from which the peak regional strain value
was determined. Global strain was deﬁned as the
peak strain value from the averaged strain curve that
was generated from 16 segmental strain curves
(global radial strain [GRS], global circumferential
strain [GCS], or 18 segmental strain curves [GLS]).
Adequacy of tracking was veriﬁed visually, and if the
tracking was deemed to be suboptimal, manual
adjustment of endocardial border was performed. If
tracking was still judged to be unsatisfactory, subjects
were excluded from the analysis.FIGURE 1 Representative Cases of 3D Speckle-Tracking Analysis
(A) A patient who had a subsequent major adverse cardiac event (MACE
global radial strain (GRS) were lower in patients with MACE compared w
circumferential strain (GCS) and global 3-dimensional strain (G3DS) betw3D SPECKLE-TRACKING ECHOCARDIOGRAPHY. A 3D
volumetric analysis and 3D strain measurements of
the left ventricle were performed using 3DSTE. 3D
full-volume datasets were analyzed using vendor-
independent 3D speckle-tracking software (4D LV
Analysis, version 3.1.2, TomTec Imaging Systems) by
an experienced investigator (Figure 1). After import-
ing 3D full-volume datasets, the apical 4-chamber,
2-chamber, and long-axis views and 3 short-axis
views at end-diastole were automatically extracted.
Nonforeshortened apical views were identiﬁed to
select the point of the apex and the center of
the mitral annular line connecting both sides of the
mitral annulus with largest LV long-axis dimensions
after which the 3D endocardial surface was automat-
ically reconstructed. The papillary muscles were in-
cluded in the LV cavity. Manual adjustments of the
endocardial surface were performed when necessary.
The same procedure was performed at the end-
systolic frame. Subsequently, the software per-
formed 3D speckle-tracking analysis throughout the
cardiac cycle. For LV volume measurements, LV
end-diastolic volume and LV end-systolic volume
were obtained as the largest and smallest volume,). (B) A patient without MACE. Global longitudinal strain (GLS) and
ith those without MACE. Note nearly the same value of global
een the 2 patients. 3D ¼ 3-dimensional.
FIGURE 2 Study P
Of 429 aortic stenos
cardiography (3DTTE
according to the inclu
ejection fraction.
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238respectively, from the time-volume curve. LV stroke
volume and LVEF were calculated as: LV end-diastolic
volume  LV end-systolic volume and LV stroke
volume/LV end-diastolic volume, respectively. For
the determination of LV mass, epicardial surface
delineation was initialized at the end-diastolic frame.
The LV mass was calculated as: (LV epicardial
volume  LV endocardial volume)  1.05 (g/ml) (17).
For 3D strain analysis, the left ventricle was auto-
matically divided into 16 segments using standard
segmentation schemes. The software provided aver-
aged longitudinal, circumferential, radial, and 3D
strain time curves from each segmental strain curve,
from which the peak global strain was determined. 3D
strain describes the tangential deformation and is
calculated as the vector sum of the longitudinal and
circumferential strain components, ignoring the
radial component. Because the software did not pro-
vide an automated evaluation of the adequacy of
image-tracking capabilities, the accuracy of tracking
was visually evaluated on the 2D images extracted
from 3D datasets. When tracking was deemed to
be inadequate, the endocardial surface was manually
readjusted as necessary. If tracking was still judged
inadequate, subjects were excluded from the analysis.opulation
is (AS) patients who underwent 3-dimensional transthoracic echo-
) at 3 institutions, the ﬁnal study population consisted of 104 patients
sion criteria. iAVA ¼ indexed aortic valve area; LVEF ¼ left ventricularFOLLOW-UP. Follow-up information was obtained
regularly in the outpatient clinic. Telephone contact
with patients, physicians, and next of kin was performed
if the patients had been treated at another hospital. If
symptoms developed, AS severity rapidly progressed, or
decreased LVEF (<50%), the attending physician
would refer the patient for AVR. Because each physician
did not have the strain measurements information,
depressed strain values did not have impact on the
decision. The primary endpoint was MACE including
cardiac death, sustained ventricular tachyarrhythmia,
AVR, and hospital admission for heart failure within
2 years of follow-up.
INTRAOBSERVER AND INTEROBSERVER VARIABILITY.
Intraobserver and interobserver variability in mea-
surements of all components of 3D global strains was
assessed in 15 randomly selected subjects, and the
reported percentage of variability was deﬁned as the
absolute difference in the percentage of the mean of
repeated measurements and intraclass correlation
coefﬁcient.
STATISTICAL ANALYSIS. Continuous variables were
expressed as the mean  SD or as the median (inter-
quartile range) according to the data distribution.
Categorical variables were presented as numbers and
proportions. All statistical analyses were performed
using commercially available software (JMP version
11.0, SAS Institute Inc., Cary, North Carolina). Differ-
ences in measurements between the 2 groups were
assessed using Student t test for continuous variables
and the chi-square test or Fisher exact test for
categorical variables whenever appropriate. Receiver-
operating characteristic (ROC) analysis was per-
formed to investigate the sensitivity and speciﬁcity
for MACE of parameters and to determine the best
cutoff value of each variable for MACE. A Kaplan-
Meier survival analysis was used to plot MACE. The
log-rank test was used to evaluate the differences
between the 2 groups. Univariate analysis was per-
formed to determine the signiﬁcant predictors of
MACE. For multivariate analysis, a separate Cox
proportional hazard model, including 1 of each
global strain parameter, was used to identify the in-
dependent variables for predicting future MACE. A
p value <0.05 was considered signiﬁcant.
RESULTS
PATIENT CHARACTERISTIC. Of 429 AS patients
for whom 3D echocardiography data were acquired
(St. Marianna University, 126 patients; University of
Tsukuba, 78 patients; and University of Occupational
and Environmental Health, 225 patients), 133 patients
TABLE 2 Baseline Echocardiographic Parameters in the Study Subjects
(N ¼ 104)
Aortic valve parameters
Peak velocity, m/s 4.05  0.80 3.00 to 6.57
Mean PG, mm Hg 39.4  17.1 20.10 to 104.00
iAVA, cm2/m2 0.42  0.10 0.19 to 0.59
Zva, mm Hg/ml/m2 4.98  1.21 2.39 to 8.04
Left chamber
LV end-diastolic volume index, ml/m2 65  19 42 to 157
LV end-systolic volume index, ml/m2 27  10 14 to 76
LV stroke volume index, ml/m2 38  10 24 to 81
LV ejection fraction, % 60  5 51 to 72
LV mass index, g/m2 89  23 49 to 213
Maximal LA volume index, ml/m2 47  18 20 to 107
E-wave, cm/s 82  31 39 to 265
A-wave, cm/s 110  27 32 to 194
E/A ratio 0.77  0.38 0.43 to 3.08
Deceleration time, ms 291  104 67 to 620
ε
0 IVS, cm/s 4.4  1.3 1.9 to 9.0
E/ε0 IVS 19.5  8.4 7.5 to 64.5
2D strain parameters, %
Global longitudinal strain 15.8  3.4 6.6 to 25.1
Global circumferential strain 26.8  6.0 6.7 to 39.3
Global radial strain 34.1  12.2 6.2 to 82.0
3D strain parameters, %
Global longitudinal strain 15.3  2.7 8.5 to 23.9
Global circumferential strain 30.6  4.0 20.6 to 40.8
Global radial strain 37.4  4.5 27.8 to 50.0
Global 3D strain 35.0  4.5 27.0 to 45.1
Values are mean  SD and range.
2D ¼ 2-dimensional, 3D ¼ 3-dimensional, iAVA ¼ indexed aortic valve area, IVS ¼ interven-
tricular septum, LA ¼ left atrial, LV ¼ left ventricular, PG ¼ pressure gradient, Zva ¼ valvu-
loarterial impedance.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5 Nagata et al.
M A R C H 2 0 1 5 : 2 3 5 – 4 5 3D Strain in Asymptomatic Severe AS
239met inclusion criteria. Subsequently, 29 patients were
excluded from analysis due to poor tracking of 3DSTE
(n ¼ 9) or a follow-up period of <2 months (n ¼ 20),
leaving 104 patients as the ﬁnal study population
(Figure 2). Baseline clinical and echocardiographic
parameters are shown in Tables 1 and 2. The majority
of patients had some cardiovascular risk factors.
The iAVA was 0.42  0.10 cm2/m2 and the mean PG
was 39  17 mm Hg. 2D speckle-tracking analysis
could not be performed in 2 patients for longitudinal
strain and 6 patients for circumferential and radial
strain due to unreliable tracking. 3D speckle-tracking
analysis was possible in all patients. The mean
values of 2DGLS, 2DGCS, and 2DGRS were 15.8 
3.4%, 26.8  6.0%, and 34.1  12.2%, respectively.
Corresponding values of 3DGLS, 3DGCS, global
3-dimensional strain (G3DS), and 3DGRS were 15.3 
2.7%, 30.6  4.0%, 35.0  4.0%, and 37.4  4.5%,
respectively. A weak but signiﬁcant correlation of
global strain values between the 2 modalities was
noted (GLS: r ¼ 0.56, p < 0.0001; GCS: r ¼ 0.31,
p ¼ 0.0021; GRS: r ¼ 0.29, p ¼ 0.0042).
CLINICAL OUTCOMES. The median follow-up was
373 days (interquartile range: 163 to 495 days). A total
of 33 patients reached the primary endpoints until 2
years, including 4 cardiac deaths, 1 ventricular ﬁbril-
lation, 11 heart failures requiring hospital admission,
and 17 AVRs due to symptom development (n ¼ 13),
depressed LVEF (n ¼ 2), and rapid hemodynamic
progression (n ¼ 2). Event-free survival in the overall
population was 72  5% and 58  7% at 1- and 2-year
follow up, respectively. Table 3 shows baseline
echocardiographic parameters and strain valuesTABLE 1 Baseline Clinical Characteristics of the Study Subjects
(N ¼ 104)
Age, yrs 78  10 (27–95)
Male 43 (41)
Body mass index, kg/m2 22.5  2.7 (16.4–29.4)
Body surface area, m2 1.50  0.17 (1.10–1.97)
Heart rate, beats/min 65  11 (39–91)
BP, mm Hg
Systolic 141  27 (82–210)
Diastolic 73  15 (36–111)
Risk factors
Hypertension 67 (64)
Diabetes mellitus 21 (20)
Hyperlipidemia 42 (40)
Coronary artery disease 19 (18)
Chronic kidney disease 48 (46)
Atrial ﬁbrillation 4 (4)
Values are mean  SD (range) or n (%).
BP ¼ blood pressure.between patients with and without events. There was
no signiﬁcant difference in clinical parameters
between the 2 groups. Peak velocity and mean PG
were signiﬁcantly higher, whereas iAVA was signiﬁ-
cantly smaller in patients with MACE compared with
those with no MACE. Although no signiﬁcant differ-
ences in LV volume were noted, maximal left atrial
(LA) volume index was signiﬁcantly larger in patients
with MACE. Among 2DSTE-derived strain parameters,
2DGLS showed signiﬁcant differences between the 2
groups. Regarding 3D strains, 3DGLS and 3DGRS were
signiﬁcantly impaired in patients with MACE com-
pared with those without MACE.
ASSOCIATIONS OF OUTCOMES. In all 7 global strain
components determined by 2DSTE and 3DSTE, the
area under the curve (AUC) calculated by ROC anal-
ysis for future MACE was largest in 3DGLS (0.78),
followed by 3DGRS (0.66) and 2DGLS (0.62). The
AUC of 3DGLS was signiﬁcantly larger than that of the
6 other global strains. 3DGLS had also the largest
AUC among other traditional echocardiographic
TABLE 3 Echocardiographic Parameters of Patients With or Without MACE
MACE (þ)
(n ¼ 33)
MACE ()
(n ¼ 71) p Value
Age, yrs 77  8 78  10 0.3717
Male 15 (45) 28 (39) 0.5627
Hypertension 20 (61) 47 (66) 0.5808
Diabetes mellitus 6 (19) 15 (21) 0.7805
Hyperlipidemia 13 (39) 29 (41) 0.9552
Coronary artery disease 6 (19) 13 (19) 0.9651
Chronic kidney disease 14 (54) 34 (52) 0.8943
Atrial ﬁbrillation 2 (6) 2 (3) 0.4394
Peak velocity, m/s 4.46  0.76 3.86  0.75 0.0002
Mean PG, mm Hg 47.8  17.0 35.5  15.9 0.0005
iAVA, cm2/m2 0.39  0.09 0.44  0.10 0.0282
Zva, mm Hg/ml/m2 4.72  1.13 5.09  1.23 0.1477
LV end-diastolic volume index, ml/m2 69  23 63  16 0.0916
LV end-systolic volume index, ml/m2 29  12 25  9 0.0868
LV stroke volume index, ml/m2 40  12 37  10 0.2096
LV ejection fraction, % 58.5  4.9 60.2  5.4 0.1456
LV mass index, g/m2 95  30 86  17 0.0640
Maximal LA volume index, ml/m2 52  23 44  14 0.0483
E/ε0 IVS 20.0  10.4 19.2  7.4 0.6597
2D global longitudinal strain, % 14.7  3.3 16.3  3.3 0.0168
2D global circumferential strain, % 26.4  7.9 27.0  4.9 0.6512
2D global radial strain, % 33.8  15.5 34.2  10.4 0.8725
3D global longitudinal strain, % 13.5  2.5 16.1  2.4 <0.0001
3D global circumferential strain, % 30.8  3.5 30. 6  4.3 0.7515
3D global radial strain, % 35.9  4.5 38.1  4.4 0.0209
Global 3D strain, % 34.9  4.1 35.1  4.0 0.8051
Values are mean  SD or n (%).
MACE ¼ major adverse cardiac event(s); other abbreviations as in Table 2.
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240parameters (Figure 3), and the AUC of 3DGLS was
signiﬁcantly larger than that of iAVA, LVEF, LV mass
index, and maximal LA volume index. ROC analysis
revealed a 3DGLS cutoff value of 14.5% had a
sensitivity of 76% and a speciﬁcity of 77% for pre-
dicting future MACE. Corresponding analysis showed
that a 3DGRS cutoff value of 39.0% had a sensitivity
of 82% and a speciﬁcity of 44% for MACE. A 2DGLS
cutoff value of 17.0% had a sensitivity of 85% and a
speciﬁcity of 48% for predicting future MACE.
Figure 4 depicts a Kaplan-Meier survival curve for the
2 groups classiﬁed by cutoff values of 2DGLS, 3DGLS,
and 3DGRS. All 3 cutoff criteria had signiﬁcant pre-
dictive power for MACE.
Table 4 shows the results of univariate and multi-
variate analyses of clinical and echocardiographic
variables. The signiﬁcant univariate factors associ-
ated with MACE (p < 0.1) were iAVA, peak velocity,
mean PG, valvuloarterial impedance, stroke volume
index, LV mass index, maximal LA volume index,
2DGLS, 3DGLS, and 3DGRS. The independent associ-
ations of outcome were analyzed using multivariate
Cox proportional hazards models. To avoid problemsof colinearity and overﬁtting the data, the LV mass
index and mean PG were selected from the parame-
ters regarding AS severity, and each strain parameter
was evaluated in separate models (Table 4). Multi-
variate analysis revealed that only 3DGLS remained
statistically signiﬁcant as a predictor of future MACE.
Because the median value of the mean PG was
35 mm Hg, more than one-half of patients had a mean
PG <40 mm Hg. To determine the prognostic value of
2DGLS/3DGLS and 3DGRS regarding the status of the
mean PG, we divided patients into 2 groups according
to the well-established cutoff value of the mean PG,
where a low PG AS is <40 mm Hg and a high PG is
$40 mm Hg (18). Both 2DGLS and 3DGLS were sig-
niﬁcant predictors of future MACE in both groups of
patients with high or low PG severe AS. 3DGRS was a
signiﬁcant predictor of MACE in a group of patients
with a low PG AS (Figure 5). These results showed that
both 2DGLS and 3DGLS manifested a signiﬁcant in-
cremental power over the mean PG for predicting
future cardiovascular events.
OBSERVER VARIABILITIES. The intraobserver vari-
ability for the 3D strain was as follows: 3DGLS, 4.4 
2.7%; 3DGCS, 4.4  3.5%; 3DGRS, 3.9  2.4%; and
G3DS, 4.9  3.2%. The corresponding interobserver
variability was 5.2  4.5%, 6.5  6.3%, 5.5  4.9%, and
7.1  4.5%, respectively. The intraobserver intraclass
correlation coefﬁcients for 3DGLS, 3DGCS, 3DGRS,
and G3DS were 0.964, 0.898, 0.936, and 0.861,
respectively. The corresponding interobserver intra-
class correlation coefﬁcients were 0.954, 0.673,
0.860, and 0.686, respectively.
DISCUSSION
To the best of our knowledge, this is the ﬁrst study to
evaluate the prognostic impact of 3DSTE-derived LV
deformation parameters in asymptomatic severe AS
patients with preserved LVEF and to directly compare
its utility with that of 2DSTE-derived strains. The
major ﬁndings of this study were as follows: 1) 2DGLS,
3DGLS, and 3DGRS were signiﬁcantly impaired in
patients with future MACE compared with those
without MACE; 2) 2DGLS, 3DGLS, and 3DGRS could
stratify a group of patients at high-risk of MACE;
3) only 3DGLS was powerful enough as an indepen-
dent predictor on multivariate analysis; and 4) sub-
group analysis according to the status of the mean PG
demonstrated that both 2DGLS and 3DGLS could
predict future MACE in low and high PG severe AS
patients.
PREVIOUS STUDIES. Of the population with severe
AS, symptomatic and asymptomatic patients with LV
FIGURE 3 Receiver-Operating Characteristic Curve Analysis for the Prediction of Major Adverse Cardiac Events
(Top left) Comparison of the area under the curve (AUC) of several strain parameters. (Top right) Comparison of AUC derived from 3DGLS and
other echocardiographic parameters. (Bottom) Statistical analysis of comparison of the AUC between the 2 variables. 2DGLS ¼ 2-dimensional
longitudinal strain; 2DGCS ¼ 2-dimensional global circumferential strain; 2DGRS ¼ 2-dimensional global radial strain; 3DGLS ¼ 3-dimensional
global longitudinal strain; 3DGCS ¼ 3-dimensional global circumferential strain; 3DGRS ¼ 3-dmensional global radial strain; G3DS ¼ global
3-dimensional strain; iAVA ¼ indexed aortic valve area; LAVI ¼ left atrial volume index; LVEF ¼ left ventricular ejection fraction; LVMI ¼ left
ventricular mass index.
FIGURE 4 Kaplan-Meier Survival Analysis for MACE
Cumulative percentage survival free from MACE according to 2DGLS (A), 3DGLS (B), and 3DGRS (C). MACE ¼ major adverse cardiac event(s);
other abbreviations as in Figure 3.
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TABLE 4 Univariate and Multivariate Analyses of Predictors of MACE
Univariate Analysis Multivariate Analysis
HR 95% CI p Value
Model 1 Model 2 Model 3
HR 95% CI p Value HR 95% CI p Value HR 95% CI p Value
Age 0.99 0.96–1.02 0.3679
Male 1.45 0.72–2.89 0.2938
BMI 1.10 0.96–1.25 0.1567
HT 0.77 0.39–1.60 0.4776
DM 0.91 0.83–2.07 0.8292
HL 0.81 0.39–1.63 0.5635
CAD 0.99 0.37–2.25 0.9773
CKD 1.04 0.48–2.30 0.9196
iAVA* 0.04 0.00–1.25 0.0665
Peak velocity* 1.95 1.36–2.74 0.0005
Mean PG 1.03 1.01–1.04 0.0008 1.02 1.00–1.04 0.0287 1.01 0.99–1.03 0.1910 1.02 1.00–1.04 0.0421
Zva 0.77 0.57–1.03 0.0739
LVSVI 1.03 1.00–1.06 0.0718
LVEF 0.95 0.89–1.02 0.1462
LVMI 1.02 1.01–1.04 0.0082 1.01 0.99–1.03 0.1678 1.01 0.99–1.03 0.1946 1.01 0.99–1.03 0.1538
LAVI† 1.02 1.00–1.04 0.0157
E/ε0 1.01 0.96–1.04 0.7616
2DGLS 1.13 1.02–1.25 0.0163 1.10 0.99–1.23 0.0726
2DGCS 1.02 0.95–1.08 0.6076
2DGRS 1.00 0.97–1.03 0.9019
3DGLS 1.46 1.26–1.71 <0.0001 1.41 1.21–1.66 <0.0001
3DGCS 0.99 0.91–1.08 0.8663
3DGRS 0.90 0.83–0.98 0.0100 0.93 0.85–1.02 0.1054
G3DS 1.02 0.94–1.12 0.6286
*Not included in the multivariable analysis due to collinearity with the mean PG. †Not included in the multivariable analysis due to collinearity with the LVMI.
BMI ¼ body mass index; CAD ¼ coronary artery disease; CI ¼ conﬁdence interval; CKD ¼ chronic kidney disease; DM ¼ diabetes mellitus; G3DS ¼ global 3-dimensional strain;
GCS ¼ global circumferential strain; GLS ¼ global longitudinal strain; GRS ¼ global radial strain; HL ¼ hyperlipidemia; HR ¼ hazard ratio; HT ¼ hypertension; IVS ¼ inter-
ventricular septum; LAVI ¼ left atrial volume index; LVEF ¼ left ventricular ejection fraction; LVMI ¼ left ventricular mass index; LVSVI ¼ left ventricular stroke volume index;
other abbreviations as in Tables 2 and 3.
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242dysfunction are Class I indications for AVR (3). How-
ever, management of asymptomatic patients with
severe AS but preserved LVEF remains controversial
(4,5). The natural history of patients with asymp-
tomatic severe AS showed a 1-year event rate ranging
from 20% to 43% (5,6,19). Although the occurrence of
sudden death without preceding symptoms is un-
common, sudden death presented in w1% to 6% of
asymptomatic severe AS patients annually (6,20).
Various studies had sought to identify high-risk
patients in this group using echocardiographic
parameters, cardiac magnetic resonance–determined
myocardial ﬁbrosis, and certain biomarkers such as
brain natriuretic peptide (19). Among them, 2D strain
analysis has emerged to show potential for both
quantifying LV mechanics and providing prognostic
information (8,9,21–23). Previous studies reported
that 2D global strains improved after AVR in patients
with AS, even though the LVEF did not change
considerably (21,22). In particular, 2DGLS has been
shown to be the most useful index to reﬂect ASseverity and symptomatic status (23). Lancellotti
et al. (9) veriﬁed that 2DGLS could differentiate high-
risk patients from low-risk patients for future cardiac
events. Yingchoncharoen et al. (10) also demon-
strated that 2DGLS has a signiﬁcant incremental value
over other clinical and echocardiographic parameters
for predicting future cardiovascular events. Because
3DSTE theoretically overcomes the limitations of
2DSTE, such as loss of speckles during through-plane
motion (12), a direct comparison of strain values by
2DSTE and 3DSTE for predicting future MACE is
imperative and clinically important.
PRESENT STUDY. The 1-year event rate was 28%,
which was in agreement with previous studies
(5,6,19). Analyses of 3DSTE-determined multidirec-
tional strains showed that 3DGLS and 3DGRS, but
not 3DGCS and G3DS, were signiﬁcantly impaired in
patients with future MACE compared with those
without. Our ﬁndings are in line with previous
observations that the impairment of longitudinal
function is closely coupled with subendocardial
FIGURE 5 Kaplan-Meier Survival Analysis for MACE According to Pressure Gradient Status
Kaplan-Meier survival analysis for MACE according to the group of patients with high PG severe AS, n ¼ 40 (A to C) and the group of patients with low PG severe AS,
n ¼ 64 (D to F). (A and D) 2DGLS. (B and E) 3DGLS. (C and F) 3DGRS. Abbreviations as in Figures 1 and 3.
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243myocardial ﬁbrosis (24). During disease progression,
myocardial ﬁbrosis gradually develops, starting at the
subendocardial layers and progressing toward the
outer myocardium. These alterations could affect LV
systolic and diastolic function, contributing to the
development of typical AS-related symptoms and
their prognosis (24). Because the early stage of
myocardial ﬁbrosis is observed at the subendocardial
layer, only longitudinal function such as GLS could
detect this abnormality. This abnormality is not well
represented by LVEF that is mainly related to global
radial thickening. Circumferential function also could
not detect this abnormality because it is related to
midwall function.
The reason for the signiﬁcant reduction in 3DGRS
in patients with events could relate to the algo-
rithm of 3DSTE software used in this study. To
analyze 3DGRS, the software performs speckletracking only in the subendocardial layer; thus,
the strain value represents subendocardial rather
than transmural function. Because radial thick-
ening increases progressively from the epicardium
toward the subendocardium, assessment of endo-
cardial radial strain is expected to detect sub-
endocardial dysfunction.
We identiﬁed several univariate echocardiographic
variables including iAVA, peak velocity, mean PG,
valvuloarterial impedance, stroke volume index, LV
mass index,maximal LA volume index, 2DGLS, 3DGLS,
and 3DGRS, which were signiﬁcantly associated with
MACE (p < 0.1). The prognostic value of all these pa-
rameters except 3DGLS and 3DGRS was already re-
ported (4,9,19). We found that 3DGLS and 3DGRS were
useful to identify high-risk patients for future MACE.
ROC analysis revealed that 3DGLS has a signiﬁcantly
larger AUC for predicting MACE compared with 2DGLS
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244and 3DGRS. Using a multivariate Cox hazard model,
only 3DGLS was still a signiﬁcantly powerful predictor
of future MACE. Subgroup analysis in patients with
low PG and with high PG severe AS showed that both
2DGLS and 3DGLS are a signiﬁcant predictor of future
MACE compared with 2DGLS. In summary, our study
identiﬁed 3DGLS as the most robust index for pre-
dicting future adverse cardiac events in asymptomatic
severe AS patients.
CLINICAL IMPLICATIONS. There are multiple mark-
ers for predicting adverse events in patients
with asymptomatic severe AS with preserved LVEF,
including increased brain natriuretic peptide,
decreased 2DGLS, exercise hemodynamic markers of
prognosis (25,26), and severity of aortic valve calciﬁ-
cation (6). In this study, the reduction of 3DGLS also
identiﬁed a high risk in asymptomatic severe AS pa-
tients with preserved LVEF. Currently no studies
have been performed to determine the appropriate-
ness of applying these parameters for the manage-
ment of asymptomatic severe AS patients. Thus,
multiple prognostic markers should be collected at
the time of assessment, and if several parameters had
already become abnormal, it might be better to
recommend that the patient undergo early AVR sur-
gery. Further prospective study is necessary to
investigate whether a 3DGLS-directed strategy is
useful to reduce sudden cardiac death in a large
number of patients with asymptomatic severe AS.
STUDY LIMITATIONS. First, only patients with good
echocardiographic images that could be adequately
analyzed for 3DSTE were enrolled; hence, there could
be a selection bias. Second, the follow-up period was
relatively short, with a median follow-up duration of
373 days. Third, due to limited physical activitiesin elderly patients, AS-related symptoms may not
develop. It is also quite difﬁcult to perform the
exercise stress test in all elderly patients to assess
their symptoms because of comorbidities such as or-
thopedic disease. Even in this setting, our results
validated that 2D/3DGLS and 3DGRS would be useful
to stratify high-risk patients with a poor prognosis.
Fourth, the small number of cardiac deaths prompted
us to also include AVR and admission for heart failure
in MACE as a primary endpoint. The decision to
perform AVR was made by individual attending
physicians. Although physicians could determine this
referral based on varying rationales for intervention,
AVR was mainly dictated by the onset of AS-related
symptoms, which is currently a Class I indication of
intervention (3).
CONCLUSIONS
In asymptomatic patients with severe AS and pre-
served LVEF, multivariate analysis revealed that
3DGLS was a powerful independent predictor of future
MACE. After ROC and subgroup analysis, we concluded
that 3DGLS is the most robust index for predicting
future adverse cardiac events in asymptomatic severe
AS patients with preserved LV function.
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